7月9日 - ** 医疗保健公司Allurion Technologies ALUR.N股价在延时交易中上涨21.7%至3.47美元
** ALUR与Minogue Medical合作 (link)，在加拿大分销减肥项目
** 加拿大医疗设备分销商Minogue Medical将提供Allurion的减肥解决方案，包括非手术胃球囊和数字护理平台。
** 该合作关系扩大了医疗服务提供商的渠道，使其能够将Allurion计划与GLP-1减肥疗法相结合
** ALUR年跌幅达73
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.